HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Complete scintigraphic lesion regression after single 153Sm-EDTMP therapy in prostate cancer.

AuthorsK Weiss, H H Köck, K Atefie, H Sinzinger
JournalRevista espanola de medicina nuclear (Rev Esp Med Nucl) Vol. 20 Issue 4 Pg. 311-2 (Jun 2001) ISSN: 0212-6982 [Print] Spain
PMID11940421 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Organometallic Compounds
  • Organophosphorus Compounds
  • Radiopharmaceuticals
  • Samarium
  • samarium Sm-153 lexidronam
Topics
  • Adenocarcinoma (diagnostic imaging, radiotherapy, secondary)
  • Bone Neoplasms (diagnostic imaging, radiotherapy, secondary)
  • Humans
  • Male
  • Middle Aged
  • Organometallic Compounds (therapeutic use)
  • Organophosphorus Compounds (therapeutic use)
  • Palliative Care
  • Prostatic Neoplasms (diagnostic imaging, radiotherapy, secondary)
  • Radionuclide Imaging
  • Radiopharmaceuticals (therapeutic use)
  • Remission Induction
  • Samarium (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: